A detailed history of Qube Research & Technologies LTD transactions in Mckesson Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 119,134 shares of MCK stock, worth $74 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
119,134
Previous 92,740 28.46%
Holding current value
$74 Million
Previous $54.2 Million 8.7%
% of portfolio
0.09%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$479.06 - $630.38 $12.6 Million - $16.6 Million
26,394 Added 28.46%
119,134 $58.9 Million
Q2 2024

Aug 14, 2024

SELL
$518.81 - $607.81 $52.7 Million - $61.8 Million
-101,647 Reduced 52.29%
92,740 $54.2 Million
Q1 2024

May 14, 2024

BUY
$473.42 - $539.26 $27.8 Million - $31.7 Million
58,764 Added 43.33%
194,387 $104 Million
Q4 2023

Feb 13, 2024

SELL
$437.42 - $470.64 $11.4 Million - $12.3 Million
-26,040 Reduced 16.11%
135,623 $62.8 Million
Q3 2023

Nov 13, 2023

BUY
$402.4 - $446.42 $15.2 Million - $16.9 Million
37,761 Added 30.48%
161,663 $70.3 Million
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $33.4 Million - $40.3 Million
94,296 Added 318.5%
123,902 $52.9 Million
Q1 2023

May 15, 2023

BUY
$335.35 - $386.06 $3.88 Million - $4.47 Million
11,567 Added 64.12%
29,606 $10.5 Million
Q4 2022

Feb 14, 2023

SELL
$346.68 - $397.58 $1.71 Million - $1.96 Million
-4,926 Reduced 21.45%
18,039 $6.77 Million
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $7.38 Million - $8.59 Million
22,965 New
22,965 $7.81 Million
Q4 2021

Feb 01, 2022

SELL
$198.21 - $248.9 $1.72 Million - $2.15 Million
-8,653 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$188.42 - $208.66 $1.63 Million - $1.81 Million
8,653 New
8,653 $1.73 Million
Q2 2021

Aug 13, 2021

SELL
$184.89 - $202.68 $4.64 Million - $5.08 Million
-25,078 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$169.52 - $196.53 $3.77 Million - $4.37 Million
-22,230 Reduced 46.99%
25,078 $4.89 Million
Q4 2020

Feb 16, 2021

BUY
$143.79 - $183.66 $701,982 - $896,628
4,882 Added 11.51%
47,308 $8.23 Million
Q3 2020

Nov 12, 2020

SELL
$140.89 - $159.9 $12.8 Million - $14.6 Million
-91,026 Reduced 68.21%
42,426 $6.32 Million
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $15.4 Million - $20.2 Million
122,442 Added 1112.1%
133,452 $20.5 Million
Q1 2020

May 15, 2020

SELL
$115.75 - $170.96 $1.23 Million - $1.82 Million
-10,643 Reduced 49.15%
11,010 $1.49 Million
Q4 2019

Feb 13, 2020

BUY
$130.23 - $153.27 $1.33 Million - $1.57 Million
10,237 Added 89.67%
21,653 $3 Million
Q3 2019

Nov 13, 2019

BUY
$134.24 - $148.53 $1.03 Million - $1.14 Million
7,671 Added 204.83%
11,416 $1.56 Million
Q2 2019

Aug 02, 2019

SELL
$112.47 - $134.93 $148,685 - $178,377
-1,322 Reduced 26.09%
3,745 $503,000
Q1 2019

May 15, 2019

BUY
$111.86 - $136.3 $50,448 - $61,471
451 Added 9.77%
5,067 $593,000
Q4 2018

Feb 14, 2019

BUY
$108.23 - $136.84 $202,823 - $256,438
1,874 Added 68.34%
4,616 $510,000
Q3 2018

Nov 14, 2018

SELL
$123.14 - $138.52 $472,734 - $531,778
-3,839 Reduced 58.33%
2,742 $364,000
Q2 2018

Aug 14, 2018

BUY
$133.4 - $158.13 $824,945 - $977,875
6,184 Added 1557.68%
6,581 $878,000
Q1 2018

May 14, 2018

BUY
$138.75 - $176.72 $55,083 - $70,157
397 New
397 $55,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.